Summary
Machine-generated summaryParticipating German statutory health insurance funds are seeking discount agreements under Section 130a(8) SGB V for the active ingredient teriparatide. The procedure is an Open-House biologics model: no individual negotiations take place, uniform conditions apply to all participants, and no exclusivity is granted. Contracts run for a maximum of 24 months starting 01.05.2026 and end at the latest on 30.04.2028 regardless of the signing date. Companies may join the Open-House procedure at any time during the contract term. Suitable pharmaceutical entrepreneurs can participate. Further details are in the participation and contract documents.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile52 open tenders right now
- Medicines - Open-House discount contracts 2026-06 - Safinamide 217 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03a - Eculizumab (excluding the gMG and NMOSD indications) 340 days left
- Medicines - Open-House Biosimilar Discount Agreements 2026-03b - Eculizumab (including the indications gMG and NMOSD) 340 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 20 | €5.3M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 10 | €4.0M | Sep 2026 |
Based on 1018 awards with a linked company profile over the last 2 years.
Change history
Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.
-
Act now
- Submission deadline: Moved 1 day EARLIER: now April 30, 2028, 00:00
- Scope and criteria: The description was expanded. Re-read it before you bid.
Follow this tender and we email you the moment it changes. Create account
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,142,739
- Buyer track record on Aperlena
- 55 notices tracked · 0 awarded
Never miss a tender like this
76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert